NSG5240 PHARM QUIZ 1 Questions
with Verified Answers
When prescribing lovastatin, what will a provider advise to decrease the risk of
developing muscle toxicity? - ANSWERSSubstitute grapefruit juice with orange juice.
A provider has prescribed a female patient a medication that induces P-glycoprotein
(PGP). The provider will be particularly concerned about which aspects of the patient's
medical history? - ANSWERSIntestinal problems, Kidney function, Liver function
An older adult patient with a history of forgetfulness will need to take multiple drugs after
discharge from the hospital. What provider action will most successfully promote
medication adherence in a forgetful patient? - ANSWERSSchedule medications to be
taken at the same times as much as possible.
A patient reports that Brand X tablets work faster than Brand Y tablets of the same
amount of the same drug. Which statement informs the prescriber's response when
explaining this phenomenon to the patient? - ANSWERSInactive ingredients used in
composition can result in differing rates of dissolution, which can alter the drug's onset
of action.
A child attending daycare is prescribed 750 mg of an antibiotic for 10 days. The drug
may be dosed in several ways and is available in two concentrations. Which dosing
regimen will the provider consider to best assure drug adherence? - ANSWERS375 mg
of a 500 mg/5 mL solution PO twice daily
Which of the following is a common side effect of opioid analgesics -
ANSWERSconstipation
When prescribing drugs with a narrow therapeutic index, what intervention does the
provider take to decrease risk to the patient? - ANSWERSMonitor the patient's plasma
drug levels at regular intervals.
A patient reports that a medication no longer effectively alleviates symptoms. What
process informs the provider's response to the patient's concerns? -
ANSWERSDesensitization of receptor sites results from continual exposure to the drug.
A provider considers prescribing tamoxifen for a woman with breast cancer. Upon
reviewing results of genetic testing, the prescriber notes that the patient has variations
in the CYP2Dy allele resulting in a deficiency of the CYP2D6 isoenzymes. What action
will this deficiency warrant in the prescribing of tamoxifen, a CYP2D6 substrate? -
ANSWERSThe tamoxifen will not be prescribed.
with Verified Answers
When prescribing lovastatin, what will a provider advise to decrease the risk of
developing muscle toxicity? - ANSWERSSubstitute grapefruit juice with orange juice.
A provider has prescribed a female patient a medication that induces P-glycoprotein
(PGP). The provider will be particularly concerned about which aspects of the patient's
medical history? - ANSWERSIntestinal problems, Kidney function, Liver function
An older adult patient with a history of forgetfulness will need to take multiple drugs after
discharge from the hospital. What provider action will most successfully promote
medication adherence in a forgetful patient? - ANSWERSSchedule medications to be
taken at the same times as much as possible.
A patient reports that Brand X tablets work faster than Brand Y tablets of the same
amount of the same drug. Which statement informs the prescriber's response when
explaining this phenomenon to the patient? - ANSWERSInactive ingredients used in
composition can result in differing rates of dissolution, which can alter the drug's onset
of action.
A child attending daycare is prescribed 750 mg of an antibiotic for 10 days. The drug
may be dosed in several ways and is available in two concentrations. Which dosing
regimen will the provider consider to best assure drug adherence? - ANSWERS375 mg
of a 500 mg/5 mL solution PO twice daily
Which of the following is a common side effect of opioid analgesics -
ANSWERSconstipation
When prescribing drugs with a narrow therapeutic index, what intervention does the
provider take to decrease risk to the patient? - ANSWERSMonitor the patient's plasma
drug levels at regular intervals.
A patient reports that a medication no longer effectively alleviates symptoms. What
process informs the provider's response to the patient's concerns? -
ANSWERSDesensitization of receptor sites results from continual exposure to the drug.
A provider considers prescribing tamoxifen for a woman with breast cancer. Upon
reviewing results of genetic testing, the prescriber notes that the patient has variations
in the CYP2Dy allele resulting in a deficiency of the CYP2D6 isoenzymes. What action
will this deficiency warrant in the prescribing of tamoxifen, a CYP2D6 substrate? -
ANSWERSThe tamoxifen will not be prescribed.
